Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Aleafia Health Inc (AH) NPV

Sell:0.52 CAD Buy:0.54 CAD Change: 0.01 CAD (1.85%)
Market closed |  Prices as at close on 4 December 2020 | Switch to live prices |
Sell:0.52 CAD
Buy:0.54 CAD
Change: 0.01 CAD (1.85%)
Market closed |  Prices as at close on 4 December 2020 | Switch to live prices |
Sell:0.52 CAD
Buy:0.54 CAD
Change: 0.01 CAD (1.85%)
Market closed |  Prices as at close on 4 December 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Aleafia Health Inc is a Canada-based vertically integrated, national cannabis company with medical clinic, cannabis cultivation and Research and Development (R&D ) operations. The Company operates a number of medical cannabis clinics staffed by physicians and nurse practitioners. The Company is differentiated, maintaining the medical cannabis dataset in the world with intellectual property holdings and current R&D operations.

Contact details

Address:
8810 Jane St 2nd Floor
CONCORD
L4K 2M9
Canada
Telephone:
+1 (902) 4054600
Website:
https://aleafiahealth.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
AH
ISIN:
CA01444Q1046
Market cap:
159.27 million CAD
Shares in issue:
301.27 million
Sector:
Health Care Facilities
Exchange:
Toronto Stock Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • Lea Ray
    Acting Independent Chairman of the Board
  • Geoffrey Benic
    Chief Executive Officer
  • Benjamin Ferdinand
    Chief Financial Officer
  • Keith White
    President of Clinic Operations
  • Greg Rossi
    Chief Operating Officer
  • David Shepherd
    Vice President of Human Resources
  • Nicholas Bergamini
    Vice President of Investor Relations
  • Robert Van den Heuvel
    Vice President of Quality & Regulatory Affairs
  • Tricia Symmes
    Chief Commercial Officer
  • Michael Verbora
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.